With two new IPCEIs getting going, we look at how they allow member states to pump money into companies without breaching EU competition rules
IPCEIs, or Important Projects of Common European Interest, are as complex as the acronym may suggest, and they’re becoming an increasingly important EU tool in funding research, development and infrastructure projects.
Last week, the Commission approved two new ones: HY2Move focused on hydrogen and mobility (the fourth one in the hydrogen series) and the first ever in health, Med4Cure, to support research, innovation and the first industrial deployment of healthcare products.
The two newest additions bring the total number of…
Discover the latest in research funding every Tuesday with Funding Newswire. Dive into detailed articles with our monthly or yearly subscriptions or start with a free trial
NOTE: if you're a part of one of our Network member organisations, you get free access by signing up with your institutional email. Verify your eligibility here.